Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Jul 31;25(8):1089-1098.
doi: 10.1093/ehjci/jeae058.

Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial

Jeff M Smit  1 , Silvia Rocchiccioli  2 , Giovanni Signore  3 , Elena Michelucci  2 , Nicoletta Di Giorgi  2 , Alexander R van Rosendael  1 , Mohammed El Mahdiui  1 , Danilo Neglia  4 , Juhani Knuuti  5 , Antti Saraste  5 , Ronny R Buechel  6 , Anna Teresinska  7 , Maria N Pizzi  8 , Albert Roque  9 , Rosa Poddighe  10 , Bart J Mertens  11 , Chiara Caselli  2 , Oberdan Parodi  12 , Gualtiero Pelosi  2 , Arthur J Scholte  1
Affiliations
Multicenter Study

Plasma lipidomics and coronary plaque changes: a substudy of the SMARTool clinical trial

Jeff M Smit et al. Eur Heart J Cardiovasc Imaging. .

Abstract

Aims: To date, no studies have investigated the association between lipid species and coronary plaque changes over time, quantitatively assessed by serial imaging. We aimed to prospectively determine the association between lipid species quantified by a plasma lipidomic analysis and coronary plaque changes according to composition assessed by a quantitative serial analysis of coronary computed tomography angiography (CTA).

Methods and results: Patients with suspected coronary artery disease (CAD) undergoing baseline coronary CTA were prospectively enrolled by seven EU centres in the SMARTool study and submitted to clinical, molecular, and coronary CTA re-evaluation at follow-up (an inter-scan period of 6.39 ± 1.17 years). Out of 202 patients who were analysed in the SMARTool main clinical study, a lipidomic analysis was performed in 154 patients before the baseline coronary CTA, and this group was included in the present study. A quantitative CTA analysis was performed by using a separate core laboratory blinded from clinical data. In the univariable analysis, it was found that no lipid species were significantly associated with annual total and calcified plaque changes. After adjusting for clinical variables at baseline and statin use, it was found that three lipid species were significantly associated with non-calcified plaque progression. In detail, cholesteryl ester(20:3), sphingomyelin (SM)(40:3), and SM(41:1) were found to be positively related to non-calcified plaque progression (Bonferroni-adjusted P-values = 0.005, 0.016, and 0.004, respectively).

Conclusion: The current study showed an independent relationship between specific lipid species determined by a plasma lipidomic analysis and non-calcified coronary plaque progression assessed by a serial, quantitative coronary CTA analysis.

Keywords: coronary artery disease; coronary computed tomography angiography; coronary plaque progression; lipid species; non-invasive coronary imaging.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A.S. received fees for consultancy or lectures from Abbot, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

Graphical Abstract
Graphical Abstract
See this image and copyright information in PMC

References

    1. Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes 2019;12:e005375. - PMC - PubMed
    1. Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med 2011;365:1812–23. - PMC - PubMed
    1. Ellims AH, Wong G, Weir JM, Lew P, Meikle PJ, Taylor AJ. Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease. Eur Heart J Cardiovasc Imaging 2014;15:908–16. - PubMed
    1. Cheng JM, Suoniemi M, Kardys I, Vihervaara T, de Boer SP, Akkerhuis KMet al. . Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Atherosclerosis 2015;243:560–6. - PubMed
    1. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Kroft LJ, Boersma Eet al. . Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease. Eur Heart J 2009;30:2622–9. - PubMed

Grants and funding